Industry News
Using Genetic Variants To Personalize Prostate Cancer Screenings
Apr 26, 2013
With the help of genetics, prostate specific antigen (PSA) screenings may become more accurate and reduce the number of unnecessary prostate biopsies, according to a new study from Northwestern Medicine®. Personalized PSA testing using genetic variants could account for an 18 percent reduction in the number of men who likely would have undergone unnecessary biopsies, according to the study... Read More
Cancer Cells' Achilles' Heel Revealed
Apr 26, 2013
Scientists from the Manchester Collaborative Centre for Inflammation Research (MCCIR) have discovered why a particular cancer drug is so effective at killing cells. Their findings could be used to aid the design of future cancer treatments. Professor Daniel Davis and his team used high quality video imaging to investigate why the drug rituximab is so effective at killing cancerous B cells... Read More
Outlook For Minority, Uninsured Pediatric Retinoblastoma Patients Worsened By Delays In Diagnosis
Apr 26, 2013
When the eye cancer retinoblastoma is diagnosed in racial and ethnic minority children whose families don't have private health insurance, it often takes a more invasive, potentially life-threatening course than in other children, probably because of delays in diagnosis, Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) researchers report at the 26th annual meeting of th... Read More
Treatment Switch For Neuroblastoma Stem Cell Transplants
Apr 26, 2013
The stem cell transplant regimen that was commonly used in the United States to treat advanced neuroblastoma in children appears to be more toxic than the equally effective regimen employed in Europe and Egypt, according to a new study being presented at the 26th annual meeting of the American Society of Pediatric Hematology Oncology in Miami April 24-27. The U.S... Read More
Successful Cancer Treatment Bodes Well For Fukushima, Other Nuclear Disaster Victims: Chernobyl Follow-Up Study
Apr 26, 2013
More than a quarter of a century after the Chernobyl nuclear disaster, many children and teenagers who developed thyroid cancer due to radiation are in complete or near remission, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).... Read More
Race, Income Linked To Breast Cancer Treatment Delays
Apr 25, 2013
Women who delay treatment for breast cancer are less likely to survive, and this is especially observed in African-Americans, Hispanics, and those of low-income... Read More
News From The Journal Of Clinical Investigation: April 24, 2013
Apr 25, 2013
An ACE in the hole for hypertension There are multiple environmental triggers that contribute to high blood pressure (hypertension), including aging, obesity, stress, alcohol intake, and excess dietary salt; however, the physiological mechanisms that are regulated by these triggers are not fully understood... Read More
Cancer Experts Detail Advanced Radiosurgery Treatments For Lung Cancer Using Varian Medical Systems Technologies
Apr 25, 2013
More than 800 oncology professionals at European Society for Radiotherapy and Oncology forum hear of pioneering treatment delivery, motion management and tumor-tracking technologies for tackling the growing lung cancer burden Cancer experts have reported future trends and progress in radiotherapy treatments for lung cancer using motion management and tumor-tracking technologie... Read More
More Intensive Follow-Op Recommended For Obese Men After Benign Prostate Biopsy
Apr 25, 2013
Obese men were more likely to have precancerous lesions detected in their benign prostate biopsies compared with non-obese men, and were at a greater risk for subsequently developing prostate cancer, according to researchers at Columbia University's Mailman School of Public Health... Read More
Vesicular Stomatitis Virus Kills Melanoma In Animal Model, Spares Normal Cells
Apr 25, 2013
Researchers from Yale University School of Medicine have demonstrated that vesicular stomatitis virus (VSV) is highly competent at finding, infecting, and killing human melanoma cells, both in vitro and in animal models, while having little propensity to infect non-cancerous cells... Read More
Previous Page Next Page